CDX2 and inflammatory bowel disease: There was no statistically significant difference in the incidence of individual genotypes between the study groups (IBD, C) in all the polymorphisms examined—rs11568820 (Cdx2) (p = 0.13), rs10735810 (FokI) (p = 0.59), rs1544410 (BsmI) (p = 0.2), rs7975232 (ApaI) (p = 0.25), and rs731236 (TaqI) (p = 0.15), and the subgroups (CD, UC, C) in all the polymorphisms examined—rs11568820 (Cdx2) (p = 0.33), rs10735810 (FokI) (p = 0.33), rs1544410 (BsmI) (p = 0.4), rs7975232 (ApaI) (p = 0.45), and rs731236 (TaqI) (p = 0.38).